Characterization, outcome and identification of prognostic factors for patients with systemic immunoglobulin lightchain amyloidosis requiring dialysis prior to initial anticlonal therapy
AL amyloidosis is a serious disease characterized by the deposition of immunoglobulin light chains in multiple organs. Renal involvement occurs in up to 70% of patients, but only a minority require dialysis before initiating anti-clonal treatment. Understanding the occurrence of end-stage organ dama...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
December 2025
|
| In: |
Haematologica
Year: 2025, Jahrgang: 110, Heft: 12, Pages: 3042-3052 |
| ISSN: | 1592-8721 |
| DOI: | 10.3324/haematol.2025.287434 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3324/haematol.2025.287434 Verlag, lizenzpflichtig, Volltext: https://haematologica.org/article/view/12118 
|
| Verfasserangaben: | Lilli S. Sester, Paolo Milani, Fenia Theodorakakou, Tobias Dittrich, Jörg Beimler, Fabian aus dem Siepen, Martin Zeier, Marc-Steffen Raab, Carsten Müller-Tidow, Efstathios Kastritis, Giovanni Palladini, Ute Hegenbart and Stefan O. Schönland |
MARC
| LEADER | 00000naa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1963115422 | ||
| 003 | DE-627 | ||
| 005 | 20260227091146.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 260227s2025 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3324/haematol.2025.287434 |2 doi | |
| 035 | |a (DE-627)1963115422 | ||
| 035 | |a (DE-599)KXP1963115422 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Sester, Lilli Sophie |d 1993- |e VerfasserIn |0 (DE-588)1238255221 |0 (DE-627)1765633842 |4 aut | |
| 245 | 1 | 0 | |a Characterization, outcome and identification of prognostic factors for patients with systemic immunoglobulin lightchain amyloidosis requiring dialysis prior to initial anticlonal therapy |c Lilli S. Sester, Paolo Milani, Fenia Theodorakakou, Tobias Dittrich, Jörg Beimler, Fabian aus dem Siepen, Martin Zeier, Marc-Steffen Raab, Carsten Müller-Tidow, Efstathios Kastritis, Giovanni Palladini, Ute Hegenbart and Stefan O. Schönland |
| 264 | 1 | |c December 2025 | |
| 300 | |b Illustrationen | ||
| 300 | |a 11 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Vorab veröffentlicht: 19. Juni 2025 | ||
| 500 | |a Gesehen am 27.02.2026 | ||
| 520 | |a AL amyloidosis is a serious disease characterized by the deposition of immunoglobulin light chains in multiple organs. Renal involvement occurs in up to 70% of patients, but only a minority require dialysis before initiating anti-clonal treatment. Understanding the occurrence of end-stage organ damage is crucial to pave the way for reversing deposition. Currently, there is no detailed analysis available for this rare patient subgroup. We conducted a systematic search across three amyloidosis centers and characterized 68 biopsy-proven AL amyloidosis patients who required dialysis prior to initial anti-clonal therapy. In our cohort, the second most affected organ was the heart. Renal parameters exhibited variability. Residual urine output and proteinuria ranged widely, while anuria had developed in only a few patients. Among the treated patients, 84% received bortezomib as first-line therapy. The median overall survival (OS) was 44.8 months, with a median event-free survival (EFS) of 16.8 months. Our univariate statistical analysis revealed that underlying clonal disease, indicated by plasma cell infiltration, but not the difference between involved (amyloidogenic) and uninvolved free light chain, impacted OS. Importantly, higher levels of Troponins were associated with worse OS, confirmed by multivariate analysis, whereas N-terminal pro-natriuretic peptide type B levels and classical echocardiographic parameters, such as septal thickness and longitudinal strain, did not demonstrate significant prognostic value. This study provides crucial insights into this unique cohort of dialysis-dependent AL amyloidosis patients. The underlying clonal disease and markers of cardiac damage are important prognostic criteria. These findings emphasize the need to refine prognostic scoring systems for dialysis-dependent AL amyloidosis patients to better stratify risk and optimize treatment approaches. | ||
| 700 | 1 | |a Milani, Paolo |e VerfasserIn |4 aut | |
| 700 | 1 | |a Theodorakakou, Fenia |e VerfasserIn |4 aut | |
| 700 | 1 | |a Dittrich, Tobias |d 1986- |e VerfasserIn |0 (DE-588)1075743141 |0 (DE-627)833664085 |0 (DE-576)444611495 |4 aut | |
| 700 | 1 | |a Beimler, Jörg |d 1968- |e VerfasserIn |0 (DE-588)115360417 |0 (DE-627)691258740 |0 (DE-576)289834899 |4 aut | |
| 700 | 1 | |a Siepen, Fabian aus dem |d 1984- |e VerfasserIn |0 (DE-588)1066499969 |0 (DE-627)817646469 |0 (DE-576)426014944 |4 aut | |
| 700 | 1 | |a Zeier, Martin |e VerfasserIn |0 (DE-588)1026480302 |0 (DE-627)726772356 |0 (DE-576)371826438 |4 aut | |
| 700 | 1 | |a Raab, Marc-Steffen |d 1973- |e VerfasserIn |0 (DE-588)124052460 |0 (DE-627)706520998 |0 (DE-576)293998027 |4 aut | |
| 700 | 1 | |a Müller-Tidow, Carsten |d 1968- |e VerfasserIn |0 (DE-588)1015101798 |0 (DE-627)705330230 |0 (DE-576)351197893 |4 aut | |
| 700 | 1 | |a Kastritis, Efstathios |e VerfasserIn |4 aut | |
| 700 | 1 | |a Palladini, Giovanni |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hegenbart, Ute |e VerfasserIn |0 (DE-588)1028373708 |0 (DE-627)73062157X |0 (DE-576)35901903X |4 aut | |
| 700 | 1 | |a Schönland, Stefan |d 1969- |e VerfasserIn |0 (DE-588)122405226 |0 (DE-627)705896137 |0 (DE-576)293255792 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Haematologica |d Pavia : Ferrata Storti Foundation, 2014 |g 110(2025), 12 vom: Dez., Seite 3042-3052 |h Online-Ressource |w (DE-627)814204899 |w (DE-600)2805244-4 |w (DE-576)424051125 |x 1592-8721 |7 nnas |a Characterization, outcome and identification of prognostic factors for patients with systemic immunoglobulin lightchain amyloidosis requiring dialysis prior to initial anticlonal therapy |
| 773 | 1 | 8 | |g volume:110 |g year:2025 |g number:12 |g month:12 |g pages:3042-3052 |g extent:11 |a Characterization, outcome and identification of prognostic factors for patients with systemic immunoglobulin lightchain amyloidosis requiring dialysis prior to initial anticlonal therapy |
| 856 | 4 | 0 | |u https://doi.org/10.3324/haematol.2025.287434 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |7 1 |
| 856 | 4 | 0 | |u https://haematologica.org/article/view/12118 |x Verlag |z lizenzpflichtig |3 Volltext |7 1 |
| 951 | |a AR | ||
| 992 | |a 20260227 | ||
| 993 | |a Article | ||
| 994 | |a 2025 | ||
| 998 | |g 122405226 |a Schönland, Stefan |m 122405226:Schönland, Stefan |d 910000 |d 910100 |d 50000 |e 910000PS122405226 |e 910100PS122405226 |e 50000PS122405226 |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 13 |y j | ||
| 998 | |g 1028373708 |a Hegenbart, Ute |m 1028373708:Hegenbart, Ute |d 910000 |d 910100 |d 50000 |e 910000PH1028373708 |e 910100PH1028373708 |e 50000PH1028373708 |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 12 | ||
| 998 | |g 1015101798 |a Müller-Tidow, Carsten |m 1015101798:Müller-Tidow, Carsten |d 910000 |d 910100 |e 910000PM1015101798 |e 910100PM1015101798 |k 0/910000/ |k 1/910000/910100/ |p 9 | ||
| 998 | |g 124052460 |a Raab, Marc-Steffen |m 124052460:Raab, Marc-Steffen |d 910000 |d 910100 |e 910000PR124052460 |e 910100PR124052460 |k 0/910000/ |k 1/910000/910100/ |p 8 | ||
| 998 | |g 1026480302 |a Zeier, Martin |m 1026480302:Zeier, Martin |d 910000 |d 910100 |d 50000 |e 910000PZ1026480302 |e 910100PZ1026480302 |e 50000PZ1026480302 |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 7 | ||
| 998 | |g 1066499969 |a Siepen, Fabian aus dem |m 1066499969:Siepen, Fabian aus dem |d 910000 |d 910100 |e 910000PS1066499969 |e 910100PS1066499969 |k 0/910000/ |k 1/910000/910100/ |p 6 | ||
| 998 | |g 115360417 |a Beimler, Jörg |m 115360417:Beimler, Jörg |d 910000 |d 910100 |e 910000PB115360417 |e 910100PB115360417 |k 0/910000/ |k 1/910000/910100/ |p 5 | ||
| 998 | |g 1075743141 |a Dittrich, Tobias |m 1075743141:Dittrich, Tobias |d 910000 |d 910100 |e 910000PD1075743141 |e 910100PD1075743141 |k 0/910000/ |k 1/910000/910100/ |p 4 | ||
| 998 | |g 1238255221 |a Sester, Lilli Sophie |m 1238255221:Sester, Lilli Sophie |d 910000 |d 910100 |e 910000PS1238255221 |e 910100PS1238255221 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1963115422 |e 4923292741 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"December 2025"}],"person":[{"given":"Lilli Sophie","family":"Sester","display":"Sester, Lilli Sophie","role":"aut"},{"role":"aut","family":"Milani","display":"Milani, Paolo","given":"Paolo"},{"given":"Fenia","family":"Theodorakakou","display":"Theodorakakou, Fenia","role":"aut"},{"role":"aut","display":"Dittrich, Tobias","family":"Dittrich","given":"Tobias"},{"role":"aut","given":"Jörg","display":"Beimler, Jörg","family":"Beimler"},{"role":"aut","given":"Fabian aus dem","display":"Siepen, Fabian aus dem","family":"Siepen"},{"display":"Zeier, Martin","family":"Zeier","given":"Martin","role":"aut"},{"display":"Raab, Marc-Steffen","family":"Raab","given":"Marc-Steffen","role":"aut"},{"family":"Müller-Tidow","display":"Müller-Tidow, Carsten","given":"Carsten","role":"aut"},{"display":"Kastritis, Efstathios","family":"Kastritis","given":"Efstathios","role":"aut"},{"family":"Palladini","display":"Palladini, Giovanni","given":"Giovanni","role":"aut"},{"role":"aut","display":"Hegenbart, Ute","family":"Hegenbart","given":"Ute"},{"display":"Schönland, Stefan","family":"Schönland","given":"Stefan","role":"aut"}],"physDesc":[{"noteIll":"Illustrationen","extent":"11 S."}],"name":{"displayForm":["Lilli S. Sester, Paolo Milani, Fenia Theodorakakou, Tobias Dittrich, Jörg Beimler, Fabian aus dem Siepen, Martin Zeier, Marc-Steffen Raab, Carsten Müller-Tidow, Efstathios Kastritis, Giovanni Palladini, Ute Hegenbart and Stefan O. Schönland"]},"title":[{"title":"Characterization, outcome and identification of prognostic factors for patients with systemic immunoglobulin lightchain amyloidosis requiring dialysis prior to initial anticlonal therapy","title_sort":"Characterization, outcome and identification of prognostic factors for patients with systemic immunoglobulin lightchain amyloidosis requiring dialysis prior to initial anticlonal therapy"}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedDisp":"2014-","publisherPlace":"Pavia","dateIssuedKey":"2014","publisher":"Ferrata Storti Foundation"}],"id":{"issn":["1592-8721"],"zdb":["2805244-4"],"eki":["814204899"]},"note":["Gesehen am 27.05.2022"],"titleAlt":[{"title":"journal of the European Hematology Association"}],"recId":"814204899","language":["eng"],"disp":"Characterization, outcome and identification of prognostic factors for patients with systemic immunoglobulin lightchain amyloidosis requiring dialysis prior to initial anticlonal therapyHaematologica","type":{"bibl":"periodical","media":"Online-Ressource"},"part":{"pages":"3042-3052","volume":"110","text":"110(2025), 12 vom: Dez., Seite 3042-3052","year":"2025","extent":"11","issue":"12"},"pubHistory":["99.2014 -"],"title":[{"title":"Haematologica","subtitle":"journal of the European Hematology Association : journal of the Ferrata Storti Foundation","title_sort":"Haematologica"}]}],"language":["eng"],"recId":"1963115422","type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"eki":["1963115422"],"doi":["10.3324/haematol.2025.287434"]},"note":["Vorab veröffentlicht: 19. Juni 2025","Gesehen am 27.02.2026"]} | ||
| SRT | |a SESTERLILLCHARACTERI2025 | ||